Alex Burshtein, Eng, MSc
Alex Burshtein has worked at BrainStorm Cell Therapeutics since its foundation as a part of the core team that set-up the company’s Research & Development (R&D) and tech-transfer projects. Alex is involved in the development of the company’s cell therapeutic product from the academic stage up to the cGMP production process, protocols, standard operating procedures (SOPs), batch records and QC methods.
Since 2013, Alex serves as the Quality Assurance Manager for the company. Before joining BrainStorm in 2005, he was a member of the original Tel Aviv University research team that developed the NurOwn® technology platform. Alex holds a Master’s degree (MSc) in Clinical Biochemistry from the Graduate School, Sackler Faculty of Medicine, Tel-Aviv University and a BSc from the Department of Chemical & Biotechnology Engineering, Ariel University.